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A B S T R A C T
Bone marrow contains cell type termed Mesenchymal Stem Cells (MSC), first recognized in bone marrow by a Ger-
man pathologist, Julius Cohnheim in 1867. That MSCs have potential to differentiate in vitro in to the various cells lines
as osteoblast, chondroblast, myoblast and adipoblast cells lines. Aims of our study were to show in vivo capacity of bone
marrow MSC to produce bone in surgically created non critical size mandible defects New Zeeland Rabbits, and then in
second part of study to isolate in vitro MSC from bone marrow, as potential cell transplantation model in bone regenera-
tion. In vivo study showed new bone detected on 3D CT reconstruction day 30, on all 3 animals non critical size defects,
treated with bone marrow MSC exposed to the human Bone Morphogenetic Protein 7 (rhBMP-7). Average values of bone
mineral density (BMD), was 530 mg/cm3, on MSC treated animals, and 553 mg/cm3 on control group of 3 animals
where non critical size defects were treated with iliac crest autologue bone graft. Activity of the Alkaline Phosphatase en-
zyme were measurement on 0.5,14,21,30 day and increased activity were detected day 14on animals treated with bone
marrow MSCs compared with day 30 on iliac crest treated animals. That results indicates strong osteoinduction activity
of the experimental bone marrow MSCs models exposed to the rhBMP-7 factor. Comparing ALP activity, that model
showed superiorly results than control group. That result initiates us in opinion that MSCs alone should be alternative
for the autolologue bone transplantation and in vitro study we isolated singles MSCs from the bone marrow of rat’s tibia
and femora and cultivated according to the method of Maniatopoulos et all. The small initial colonies of fibroblast like
cells were photo-documented after 2 days of primary culture. Such isolated and cultivated MSCs in future studies will be
exposed to the growth factors to differentiate in osteoblast and indicate their clinically potential as alternative for conven-
tional medicine and autologue bone transplantation. That new horizons have potential to minimize surgery and patient
donor morbidity, with more success treatment in bone regenerative and metabolism diseases.
Key words: mesenchymal stem cells, regenerative medicine, bone regeneration
Introduction
Bone marrow contains at least two, and likely more1,2,
discernable stem cell populations. Besides the hemato-
poietic stem cell which produces blood cell progeny, a cell
type termed Mesenchymal Stem Cells (MSCs) or stromal
also exists in marrow. MSCs were first recognized in
bone marrow as a non-hematopoietic stem cell by a Ger-
man pathologist, Julius Cohnheim in 18673. The isola-
tion and exploration on the differentiation potential of
MSCs have been an issue of research for more than three
decades3.
Human MSC have been shown to differentiate in vi-
tro into various cell lineages including neuronal cells4,5,
as well as cartilage, bone, and fat lineages6. Also MSCs
have been induced to form hepatocytes in culture7 and
liver-specific gene expression has been induced in vitro in
human bone marrow stem cells8.
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Numerous references now document the ability of
these adult stem cells to contribute to regeneration of
cardiac tissue and improve performance of damaged
hearts. In animal studies, for example rat9, mouse10 and
human11 stem cells have been identified as integrating
into cardiac tissue, forming cardiomyocytes and/or car-
diac blood vessels, regenerating infarcted heart tissue,
and improving cardiac function. In mice, bone marrow
derived stem cells injected into old animals seem capable
of restoring cardiac function12, apparently through in-
creased activity for cardiac blood vessel formation. The
evidence has led numerous groups to use bone marrow
derived stem cells in treatment of patients with damaged
cardiac tissue13,14. Results from these clinical trials indi-
cate that bone marrow derived stem cells, including cells
from the patients themselves, can regenerate damaged
cardiac tissue and improve cardiac performance in hu-
mans. Tateishi-Yuyama et al.15, have shown that bone
marrow derived stem cells from the patients themselves
can improve blood circulation in gangrenous limbs, in
many cases obviating the need for amputation.
Rodents (rabbit, rat and mouse) MSCs are classically
obtained from the femurs and tibias, by flushing the
marrow out of the bones with culture medium and trans-
ferring the resultant cell suspension in culture16. Human
MSCs can be similarly obtained from healthy volunteers
by taking aspirates of bone marrow from the iliac crest
and expanding on tissue-culture plastic17. The tradi-
tional isolation method relies on the fact that MSCs se-
lectively adhere to plastic surfaces, whereas hemato-
poietic cells do not and can therefore be removed through
medium changes, by serial passaging and after a number
of passages the culture is enriched in the self-renewing
fraction, the stem cells18.
In this study we want to show in vivo capacity of the
bone marrow MSC to produce bone in non critical size
defects of rabbit’s mandibles. In second part of study we
would like to address in vitro isolation and cultivation of
the MSC derived from the bone marrow, as potential cell
transplantation model for bone regeneration and alter-
native for conventional bone grating.
Material and Methods
For in vivo study we used total of 6 White New
Zealand Rabbits. Animals were anesthetized with injec-
tion of the 1mg. Ketamine hydrochloride (Veterinary
Ketalar) administered intramuscularly. With sub mandi-
ble approach, using dental micro motor and drill, unilat-
erally non critical defect of mandibles were created on all
animals. Untreated, such kind of defect would healing in-
complete with fibrous and scar tissue, pseudoarthrosis
and dysfunction. Defect of mandible was firmly fixed
bicortically with titanium mini plate. On three animals
defects were treated with autologue bone marrow ob-
tained from the resection particle of mandible and mixed
with the growth factor recombinant human Bone Mor-
phogenetic Protein-7 in concentration of 100 micrograms
in collagen as carrier. On the control group of other three
animals defects were treated with bicortical autologue
bone graft from crest iliac.
Results were detected by measurement Alkaline Pho-
sphatase (ALP) enzyme activity on 5, 14, 21, 30 postoper-
ative days, and by 3D C-T images with slices 1mm thick,
taken after 30 days. That 3D CT images were analyzed
for the Bone Mineral Density (BMD, mg/cm3) using
GEANIE 2.0 software (BonAlyse Ltd.). During C-T re-
cording animals were anesthetized with 1 mg Ketamine.
In vitro study the stem cells were isolated from the
bone marrow of rat’s tibia and femora and prepared ac-
cording to the method of Maniatopoulos et al.19. The ani-
mals 5–6 week old were used, because the donor age af-
fects the amount of mineralized tissue (20). Both sites
femora and tibia were aseptically removed after sacrifice
under chloroform anesthesia asphyxiation according to
Institutional Animal Care and Use Committee (IACUC)
guidelines. The adherent soft tissues were thoroughly
debrided and the bone is washed 5 times with phosphate
buffered saline (PBS). After the epiphyses were removed,
an 18-gauge needle, attached to a 10-ml syringe was used
to bore a small opening through the growth plate on the
distal end of the femora and the proximal end of the tib-
iae. A 10-ml syringe fitted with a sterile 18-gauge needle
was filled with alpha minimal essential medium supple-
mented with 10% fetal bovine serum (FBS). The needle
was inserted into the opening previously prepared, and
5ml of medium was ejected to expel the bone marrow
from the medullary canal. Marrow samples were col-
lected suspended and inoculated in the 75 cm3 cell flask
with 15 ml medium. The cells are stored and maintained
at 37C in a humidified atmosphere, consisting of 95% air
and 5% CO2. To prevent bacterial contamination we use
Penicillin 50UI/l, Streptomycin 50 micrograms/ml, Fun-
gizone 0.3 micrograms/ml and Gentamicine Sulphate 50
micrograms/ml, dissolved in the medium before filtra-




Mean values of ALP activity observed preoperative
and 5th, 14th, 21th, 30th postoperative day are present in
Table 1. Significant higher mean values of ALP activity
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TABLE 1
MEAN VALUES OF ALP ACTIVITY MEASUREMENT ON DEFECTS
TREATED WITH BMMSC&rhBMP-7 (3 ANIMALS) AND
BICORTICAL BONE GRAFT TREATED SITES (3ANIMALS)
bicortical bone
graft
29.02 27.49 22.65 27.03 54.38
BM
MSC&rhBMP-7
41.3 18.48 38.49 44.03 48.72
Days 0 5 14 21 30
BMMSC&rhBMP7- bone marrow mesenchymal stem cells and
recombinant human bone morphogenetic protein 7
were detected 14th postoperative day on animals treated
with BMMSC& rhBMP-7/ACS with 0.050 level of signifi-
cance, than in control group of bone graft treated sites 30
day with 0.010 level of significance (Table 2).
C-T and BMD evaluation
Examinations C-T scans and analyzing BMD using
GENAUINE 2.0 program are present in Figure 1a and b.
Average values of the BMD determinate by the GEA-
NIE 2.0 BonAlyse program 3 animals treated with the BM
MSC&rhBMP-7 and 3 animals treated with bicortical
bone graft, 30th postoperative day are showed in Table 3.
In vitro isolation MSCs from bone marrow
The small initial colonies of fibroblast like cells were
photo-documented after 2 days of primary culture what
is showed in Figure 2. There are present initial colonies
of the stem cells attached for the floor of flask. They are
of airy consistence, star like shape with nucleus in the
middle. Around them are roundish truss like confluent
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TABLE 2
TIME COURSE INTERVAL OF THE DIFFERENCES MEAN VALUES OF ALP ACTIVITY BMMSC&rhBMP-7 AND BONE GRAFT TREATED
SITES
Significances t df Sig t df Sig t df Sig t df Sig t df Sig
Bicortical bone graft 2.4/2/0.131 6.8/2/0.020 7.8/2/0.016 19.1/2/0.003 10.0/2/0.010
BM MSC&rhBMP 12.9/2/0.006 16.9/2/0.003 4.0/2/0.050 5.1/2/0.035 12.8/2/0.006
Days 0 5 14 21 30
BMMSC&rhBMP7- bone marrow mesenchymal stem cells and recombinant human bone morphogenetic protein 7
a) Fig 1. a). 3D C-T film non critical size defect treated with BM
MSC& rhBMP-7 with radiopaque higher density area entire of
defect 30 day; b) Cross-sectional scanning images of the resected
mandibles by GEANIE 2 BonAlyse program and BMD analyzing.
b)
hematopoietic cells, which during the experiment should
be eliminated during media changes by aspiration and
flushing, and stem cells will continue to reproduce and
cultivate.
Discussion
This in vivo study showed that bone marrow exposed
to the growth factor BMP-7 has strong osteoinductive re-
sponse detected by ALP activity and BMD measure-
ments. Even that, showed more superior osteoinductive
effect than gold standard in bone reconstruction, bicor-
tical bone graft, detected by significantly increase ALP
activity 14 day, compared with 30 day on bone graft sites.
The reason for that should be fact that bone marrow is
contains of the stem cells20,21. Also we suppose that exces-
sive bone formation observed 30th day on CT film origi-
nated due excess response stem cells to the rhBMP-7, and
their osteoinduction signaling mechanism.
Judging from the results of this in vivo experiment,
our next intention was to isolate stem cells from bone
marrow, as future cells transplantation model. The im-
portant technical point was that the culture medium con-
taining fetal bovine serum.
Most cells which do not attach to the culture dish sur-
face were removed by aspiration at the first medium
change, 24 hours after cell inoculation, and a very small
number of fibroplastic stem cells remain. When the cells
are prepared in this way and cultured under the above
condition, the majority of the hematopoetic cells die and
stromal fibroplastic colonies are formed. Marrow cells
give rise to fibroplastic MSC colonies in culture and each
colony is derived from a single cell, what was in accor-
dance with method described by Friedenstein3.
Fibroplast MSC colony forming cells are termed a
fibroplastic colony forming unit (CFU-F). Ergise et al.22,
reported that the bone marrow of a 4-mount old rat form
more fibroblastic colonies than the bone marrow of a
21-month old rat, indicating a decrease in CFU-Fs in
bone marrow with aging. Some CFU-Fs, which consist of
osteoprogenitor cells, have the capacity to produce bone
like mineralized nodules. Thus, we can estimate the
number of osteoprogenitor cells in bone marrow tissue
by counting the mineralized – nodules in this culture sys-
tem. Also we used in study mice between 4 and 6 week
old to obtain the optimum sample for obtaining CFU-F
MSC.
BM MSC expansion potential, ease of isolation, com-
patibility with multiple delivery methods and most im-
portantly their immunosuppressive properties have gen-
erated great expectations in cell-based therapeutics23,24.
The bone graft transplantation should be replace in fu-
ture and bone harvesting with their morbidity and neces-
sarily for adding operative procedures become history.
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IN VIVO OSTEOINDUKTIVNI EFEKT I IN VITRO IZOLACIJA I KULTIVACIJA MEZENHIMALNIH
MATI^NIH STANICA KO[TANE SR@I
S A @ E T A K
Ko{tana sr` sadr`i stanice koje se zovu mezenhimalne mati~ne stanice (MMS) koje su prvi put identificirane u
ko{tanoj sr`i od strane njema~kog patologa Julija Cohnheima 1867 godine. Utvr|eno je da MMS imaju potencijal da se
diferenciraju in vitro u razli~ite tipove stanice kao {to su osteoblasti, hondroblasti, mioblasti i adipoblasti. Ciljevi ovog
istra`ivanja su da se in vivo poka`e sposobnost MMS iz ko{tane sr`i da proizvedu novu kost kod kirur{ki stvorenih
defekata nekriti~ne veli~ine kod novozelandskih kuni}a. U drugom dijelu studije da se izoliraju in vitro MMS iz ko{tane
sr`i, kao potencijalni model stanica u regeneraciji kosti. In vivo studija je pokazala postojanje novog dijela kosti na 3D
CT rekonstrukciji. Nakon 30 dana kod sve 3 `ivotinje sa defektom nekriti~ne veli~ine tretiranih sa MMS iz ko{tane sr`i
izlo`ene su ljudskom ko{tanom morfogenskom proteinu 7 (rhBMP-7). Prosje~na vrijednost mineralne gusto}e kostiju
(BMD) iznosila je 530 mg/cm3 kod s MMS tretiranim `ivotinjama, a 553 mg/cm3 u kontrolnoj skupini u kojoj su 3
`ivotinje tretirane zbog defekata nekriti~ne veli~ine sa autolognim graftom ilija~ne kosti. Aktivnosti enzima alkalne
fosfataze su mjerene tokom 0, 5, 14, 21, 30 dana te je pove}ana aktivnost otkrivena 14 dana kod `ivotinja tretiranih sa
MMS iz ko{tane sr`i u usporedbi s 30 danom kod `ivotinja lije~enih autolognim graftom. Ovaj rezultat ukazuje na
sna`an osteoindukcioni efekat djelovanja eksperimentalnog modela MMS ko{tane sr`i izlo`enog rhBMP-7 faktoru.
Upore|uju}i ALP aktivnosti ovaj je model pokazao superiornije rezultate u odnosu na kontrolnu skupinu. Ovaj rezultat
inicira na mi{ljenje da bi MMS metoda trebala biti alternativa za autolognu transplantaciju, te su u in vitro ispitivanju
izolirane pojedina~ne MMS iz ko{tane sr`i tibije i femura {takora i kultivirane prema metodi Maniatopoulos et al. Male
po~etne kolonije stanica fibroblasta su fotografski dokumentirane nakon 2 dana od primarne kulture. Takve izolirane i
kultivirane MMS }e tokom studija u budu}nosti biti izlo`ene faktorima rasta i diferencirati se u osteoblaste te ukazati
na njihov klini~ki potencijal kao alternativu za metode konvencionalne medicine i autolognu transplantaciju kosti. Ovi
novootvoreni horizonti ukazuju na potencijal minimiziranja kirur{kih zahvata kao i morbiditeta bolesnika i donatora,
uz vi{e uspjeha u lije~enju kod regenerativnih i metaboli~kih oboljenja kostiju.
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